Ankylosing spondylitis (AS) is the second most common type of inflammatory arthritis, often affecting teenagers and young adults. Symptoms of AS can include back pain, stiffness, joint inflammation ...

Most people with ankylosing spondylitis (AS) develop pain and stiffness in their lower back, but it’s not uncommon to also develop symptoms in other joints. Ankylosing spondylitis (AS) is a type of ...

Ankylosing spondylitis and scoliosis both affect your spine, but they are different conditions. Scoliosis is an atypical sideways curve in your spine that can lead to back pain. It’s estimated to ...

Morning back pain can signal more than just back muscle stiffness. A new review suggests that whole body cryotherapy could be the answer to address ankylosing spondylitis. Here's how you can identify ...

Ankylosing spondylitis (AS) is a chronic inflammatory condition that mainly affects the spine. The condition usually requires medical treatments, but some home remedies can also reduce symptoms. AS is ...

For decades, ankylosing spondylitis was considered a man’s disease, but new research reveals something shocking: ankylosing spondylitis hits women differently and nearly as frequently as men, yet ...

Pregnancy is one of the most beautiful journeys you’ll ever take. But if you’re living with ankylosing spondylitis (AS), you might also have a few worries running through your mind. You may wonder how ...

Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints (those between the spine and hipbone). Less commonly, AS can affect other joints such ...

A debilitating autoimmune condition silently attacks the spine and surrounding joints, causing inflammation that gradually transforms flexible vertebrae into rigid, fused bone. Ankylosing spondylitis ...

Natural treatments for ankylosing spondylitis (AS), a type of inflammatory arthritis, can help you to deal with pain and stiffness in the spine and other joints. Exercise, nutrition, and smoking ...

Bimekizumab demonstrated safety and efficacy at 2 years among patients with nonradiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS). Bimekizumab is currently FDA approved ...